Cardiovascular risks of coxibs: the orthopaedic perspective.
Bhattacharyya
Timothy
T
Smith
R Malcolm
RM
D003324:Coronary Artery Disease / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D009140:Musculoskeletal Diseases / Q000150:complications*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D018570:Risk Assessment
D016861:Cyclooxygenase Inhibitors; D011464:Epoprostenol